What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Myocardial infarction
Karl Werdan spends much of his time researching Internal medicine, Cardiology, Sepsis, Endocrinology and Cardiogenic shock.
His Internal medicine research is multidisciplinary, incorporating elements of Surgery and Intensive care.
Karl Werdan combines subjects such as Autonomic nervous system, Heart rate, Mortality rate and Cardiac pacemaker with his study of Sepsis.
His Cardiogenic shock study contributes to a more complete understanding of Myocardial infarction.
His Myocardial infarction study combines topics from a wide range of disciplines, such as Survival rate, Shock and Cardiac index.
His Heart failure research includes elements of Anesthesia and Heart disease.
His most cited work include:
- Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock (1300 citations)
- Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial (712 citations)
- Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial (539 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Cardiology, Sepsis, Endocrinology and Myocardial infarction are his primary areas of study.
In the field of Internal medicine, his study on Cardiogenic shock, Shock and Heart failure overlaps with subjects such as In patient.
His Cardiogenic shock research incorporates elements of Myocardial infarction complications, Randomized controlled trial and Revascularization.
His work carried out in the field of Cardiology brings together such families of science as Heart rate variability and Heart rate.
His Sepsis research is multidisciplinary, incorporating perspectives in APACHE II and Intensive care medicine.
Karl Werdan has included themes like Receptor and Ouabain in his Endocrinology study.
He most often published in these fields:
- Internal medicine (51.48%)
- Cardiology (31.58%)
- Sepsis (15.62%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (51.48%)
- Cardiology (31.58%)
- Myocardial infarction (13.32%)
In recent papers he was focusing on the following fields of study:
Karl Werdan mostly deals with Internal medicine, Cardiology, Myocardial infarction, Cardiogenic shock and Shock.
His research on Internal medicine often connects related topics like Endocrinology.
His study in the field of Percutaneous coronary intervention, Conventional PCI and Heart failure also crosses realms of In patient.
His Myocardial infarction study also includes
- Hazard ratio which intersects with area such as Proportional hazards model,
- Intensive care medicine together with Sepsis.
His studies in Cardiogenic shock integrate themes in fields like Percutaneous, Surgery, Myocardial infarction complications, Myocardial infarction diagnosis and Revascularization.
His work deals with themes such as Intraaortic balloon and TIMI, which intersect with Shock.
Between 2011 and 2021, his most popular works were:
- Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock (1300 citations)
- Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial (712 citations)
- Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial (539 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Myocardial infarction
Karl Werdan mainly investigates Internal medicine, Myocardial infarction, Cardiology, Cardiogenic shock and Shock.
Internal medicine connects with themes related to Endocrinology in his study.
His Myocardial infarction research integrates issues from Incidence, Surgery, Intensive care medicine, Stroke and Hazard ratio.
His research integrates issues of Myocyte and Prospective cohort study in his study of Cardiology.
Karl Werdan has researched Cardiogenic shock in several fields, including Angioplasty, Conventional PCI, Percutaneous coronary intervention, Randomized controlled trial and Myocardial infarction complications.
His Shock study also includes fields such as
- Myocardial infarction diagnosis which intersects with area such as Guideline, Systemic inflammatory response syndrome, SAPS II and Intensive care,
- Intraaortic balloon, which have a strong connection to Intra-Aortic Balloon Pumping and Intraaortic balloon pump.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
